Manufacturing and Production

Showing 15 posts of 5866 posts found.

EMA eSubmission Gateway now live

May 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …

Novartis will restart production at Lincoln plant in May

May 1, 2012 Manufacturing and Production FDA, GMP, Lincoln, Nebraska, Novartis, manufacturing

Novartis chief executive Joe Jimenez has said that production at the firm’s troubled consumer health plant in Lincoln, Nebraska, will …
FDA picture

FDA approves greener process for Januvia production

May 1, 2012 Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing

The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …

Pharma manufacturing news in brief

May 1, 2012 Manufacturing and Production Aptar Pharma, Ark Therapeutics, Cambrex, Eckert & Ziegler, Granules India and Omkar Speciality Chemicals

Cambrex facility passes FDA inspection, low-cost inhaler launched by Aptar, plus updates from Eckert & Ziegler, Granules India and Omkar …

New ABPI president appointed

April 30, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …

New head at Bayer’s Animal Health division

April 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …

Brennan bows to pressure and quits AstraZeneca

April 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …

Merck KGaA swings axe over Serono operations

April 25, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …
Novartis image

Novartis to invest $550m in new Swiss plant

April 24, 2012 Manufacturing and Production GSK, Novartis, manufacturing and production

Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …

7 steps to better talent acquisition

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, Talent acquisition, careers, executives

When companies complain that they can’t find enough good people, the cause, in our view, is most likely to be …
tom_pike_500_pixels_wide_-_quintiles

Quintiles appoints Tom Pike as new chief executive

April 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Quintiles, Tom Pike, biopharmaceutical

Quintiles, the biopharmaceutical services company, has appointed Tom Pike as its new chief executive, effective from 30 April. The appointment …

GSK to bring pharma plant in Sri Lanka online

April 24, 2012 Manufacturing and Production BMS, GSK. Sri-Lanka, manufacturing and production

GlaxoSmithKline is due to open a newly-built manufacturing facility in Sri Lanka this week that is said to be the …

Mylan earmarks €380m for Irish expansion

April 24, 2012 Manufacturing and Production Galway, Ireland, Mylan, manufacturing and production

Generic drugmaker Mylan has announced a plan to invest €380 million in its operations in the Republic of Ireland, including …

Baxter planning $1 billion plasma facility for Atlanta

April 24, 2012 Manufacturing and Production Atlanta, baxter, manufacturing, production

Baxter International has unveiled plans to build a major new manufacturing complex for its plasma-based therapies in Atlanta in the …

Falsified Medicines Directive in the EU

April 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dated 16 April 2012, the European Commission has issued the Draft Template for the Written Confirmation for Active Substances Imported …
The Gateway to Local Adoption Series

Latest content